Bottlenecks in the Efficient Use of Advanced Therapy Medicinal Products Based on Mesenchymal Stromal Cells
Mesenchymal stromal cells (MSCs) have been established as promising candidate sources of universal donor cells for cell therapy due to their contributions to tissue and organ homeostasis, repair, and support by self-renewal and multidifferentiation, as well as by their anti-inflammatory, antiprolife...
Main Authors: | Natalia Escacena, Elena Quesada-Hernández, Vivian Capilla-Gonzalez, Bernat Soria, Abdelkrim Hmadcha |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2015-01-01
|
Series: | Stem Cells International |
Online Access: | http://dx.doi.org/10.1155/2015/895714 |
Similar Items
-
Therapeutic Potential of Mesenchymal Stem Cells for Cancer Therapy
by: Abdelkrim Hmadcha, et al.
Published: (2020-02-01) -
Human Mesenchymal Stem Cells Prevent Neurological Complications of Radiotherapy
by: Bernat Soria, et al.
Published: (2019-05-01) -
The Bottlenecks in Translating Placenta-Derived Amniotic Epithelial and Mesenchymal Stromal Cells Into the Clinic: Current Discrepancies in Marker Reports
by: Seyyed-Hadi Ghamari, et al.
Published: (2020-03-01) -
Mesenchymal Stromal Cell-Based Therapies as Promising Treatments for Muscle Regeneration After Snakebite Envenoming
by: E. Eduardo Sanchez-Castro, et al.
Published: (2021-02-01) -
Advancing mesenchymal stem/stromal cells-based therapies for neurologic disease
by: Donald G Phinney
Published: (2017-01-01)